Liquidity and Capital Resources (Details)			1 Months Ended		2 Months Ended	3 Months Ended		6 Months Ended		12 Months Ended
	Apr. 30, 2025 USD ($) $ / shares shares	Aug. 24, 2022 USD ($)	Feb. 28, 2025 USD ($) Director $ / shares shares	Apr. 30, 2024 USD ($)	Feb. 28, 2025 USD ($) Corporation $ / shares shares	Jun. 30, 2025 USD ($) $ / shares shares	Jun. 30, 2024 USD ($) shares	Jun. 30, 2025 USD ($) $ / shares shares	Jun. 30, 2024 USD ($) shares	Dec. 31, 2024 USD ($) shares	Aug. 31, 2022 USD ($)
Liquidity [Abstract]
Cash and cash equivalents						$ 31,873,495		$ 31,873,495		$ 41,689,591
Registered securities in Shelf Registration Statement											$ 150,000,000
Proceeds from issuance of common stock								$ 6,994,174	$ 0
Proceeds from sale of tax benefits				$ 900,000	$ 1,200,000
Number of New Jersey corporations purchasing tax benefits | Corporation					2
Exercise price of warrants (in dollars per share) | $ / shares	$ 2.52					$ 2.52		$ 2.52
Loan repayment								$ 18,645,833	$ 0
Sales Agreement and New Sales Agreement [Member]
Liquidity [Abstract]
Placement Shares available for sale											$ 97,000,000
Sales Agreement [Member]
Liquidity [Abstract]
Commission paid on Placement Shares sold											3.00%
Issuance of common stock (in shares) | shares							0		3,428,681	3,428,681
Proceeds from issuance of common stock							$ 0		$ 19,500,000	$ 19,500,000
New Sales Agreement [Member]
Liquidity [Abstract]
Issuance of common stock (in shares) | shares						960,511		1,165,861		1,108,105
Proceeds from issuance of common stock						$ 1,500,000		$ 1,800,000		$ 3,200,000
February 2025 Offering [Member]
Liquidity [Abstract]
Aggregate shares to be sold (in shares) | shares			6,396,787		6,396,787
Number of directors participating in securities offering | Director			2
Combined purchase price per share and warrant (in dollars per share) | $ / shares			$ 1.5		$ 1.5
Gross proceeds from securities offering			$ 11,000,000
Net proceeds from securities offering			$ 10,050,000.00
February 2025 Offering [Member] | Directors [Member]
Liquidity [Abstract]
Aggregate number of shares purchased in securities offering (in shares) | shares			30,121
Offering price per share (in dollars per share) | $ / shares			$ 1.66		$ 1.66
February 2025 Offering [Member] | Pre-funded Warrants [Member]
Liquidity [Abstract]
Number of shares of common stock that can be called by warrants (in shares) | shares			933,334		933,334
February 2025 Offering [Member] | Common Stock Warrants [Member]
Liquidity [Abstract]
Number of shares of common stock that can be called by warrants (in shares) | shares			7,330,121		7,330,121
February 2025 Offering [Member] | Common Stock Warrants [Member] | Directors [Member]
Liquidity [Abstract]
Number of shares of common stock that can be called by warrants (in shares) | shares			30,121		30,121
Exercise price of warrants (in dollars per share) | $ / shares			$ 1.53		$ 1.53
Maximum [Member]
Liquidity [Abstract]
Number of shares of common stock that can be called by warrants (in shares) | shares	1,000,000					1,000,000		1,000,000
Maximum [Member] | Sales Agreement [Member]
Liquidity [Abstract]
Placement Shares available for sale											$ 50,000,000
Loan and Security Agreement [Member]
Liquidity [Abstract]
Proceeds from issuance of secured loans		$ 24,600,000
Loan repayment	$ 19,000,000
Debentures [Member]
Liquidity [Abstract]
Face amount	22,222,222
Proceeds from issuance	$ 20,000,000
Cash amount used to determine minimum cash balance						$ 15,000,000		$ 15,000,000
Cash added to outstanding principal amount of Debentures used to determine minimum cash balance						3,000,000		3,000,000
Maximum redemption amount per calendar month						$ 500,000		$ 500,000